
The Israeli military has said that Iran’s weapons production capabilities will be largely destroyed "within a few days."
Over the coming days, the military aims to "complete their attacks on all key components of the [Iranian] military industry," army spokesman Effie Defrin told journalists on Saturday evening.
"This means that we will have destroyed most military production capabilities," he added.
"It will take the regime a long time to rebuild them."
Since Israel and the US began to attack Iran four weeks ago, the Israeli Air Force has been carrying out heavy strikes on Iran's military industry.
The Israeli military estimates that it has already struck around 90% of the key facilities in the Iranian arms industry, according to the Times of Israel.
Israeli fighter jets also bombed military production facilities in Iran overnight, including the headquarters of the Marine Industries Organization which is responsible for the development and construction of warships and submarines.
latest_posts
- 1
NASA shares first photos of Earth taken by Artemis II - 2
Fundamental Home Machines for Improved Solace in Summer - 3
Addressing sleep apnea early might decrease chances of developing Parkinson's disease - 4
Figure out How to Keep up with Oral Wellbeing During Pregnancy - 5
UAE recalls some Nestle infant formula products, Qatar warns consumers
Former GLP-1 users regain lost weight after about 18 months, study says
Oldest sequenced RNA reveals details about a mammoth’s final moments 40,000 years
I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
Colleges say foreign students feel 'unwelcome' in the U.S. amid big drop in international enrollment, new survey finds
Who was Haytham Ali Tabatabai, Hezbollah's military leader killed by Israel?
Reactions as Artemis II astronauts lift off on historic lunar mission
NASA's Artemis II launch leaves Americans in awe: 'We're going back to the frickin' moon!'
Former biotech CEO sued over COVID vaccine alleged insider trading
Merck sees over $5 billion opportunity in Cidara's experimental flu drug













